IAM

Iambic Therapeutics Inc.

There isn't enough reported data to score IAM yet.

IAM Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Unavailable

There isn't enough reported data to rate IAM's fundamentals.

IAM PE Valuation

IAM has no meaningful PE right now: it lost money over the past year.

IAM Forward outlook

There aren't enough analyst estimates for IAM to show an outlook.

IAM Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $14.84 on Nov 12.

There is not enough scenario data to assess IAM's risk to reward.

IAM Earnings Per Share

IAM Quarterly Revenue

IAM Free Cash Flow

IAM Total Shares

IAM Net Leverage

IAM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

IAM Weekly Momentum

As of the close on Nov 12, 2026: $14.84.

IAM PE vs Healthcare Sector

IAM has no meaningful PE right now: it lost money over the past year.

IAM Weekly Moving Averages

As of the close on Nov 12, 2026: $14.84.

IAM Yearly ROI

YearStart priceEnd priceROI
2026 YTD$23.8$14.8-38%

It's down 38% so far in 2026.

Give your agent the market.

Get API key